ClonoSEQ minimal residual disease testing in multiple myeloma patients saves costs in Germany
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2017 ◽
Vol 2
(1)
◽
pp. 118-122
Keyword(s):
Keyword(s):
Keyword(s):